Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

News Conference News EuroPCR 2024

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

Caitlin E. Cox

May 16, 2024

News Daily News

Interventional Cardiology Training Needs Defined for the First Time

Yael L. Maxwell

February 20, 2023

News Daily News

No Stents in STEMI? With Careful Selection, Maybe

Caitlin E. Cox

March 21, 2022

News Conference News EuroPCR 2021

Transradial PCI Bests Femoral Access in Complex Cases: COLOR

Michael O'Riordan

May 21, 2021

News Daily News

FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries

Shelley Wood

February 16, 2021

News Conference News TCT 2020

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

Caitlin E. Cox

October 18, 2020

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Caitlin E. Cox

November 16, 2019

News Conference News TCT 2019

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Todd Neale

September 28, 2019

News Daily News

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Michael O'Riordan

October 17, 2018

News Daily News

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

Yael L. Maxwell

June 16, 2017

News Conference News ACC 2017

People Living in Amazon Rainforest Provide Clues to Coronary Protection

L.A. McKeown

March 17, 2017

News Daily News

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Michael O'Riordan

September 27, 2016

News Daily News

CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study

Michael O'Riordan

September 22, 2016

News Conference News ESC 2016

When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis

Michael O'Riordan

August 31, 2016

News Conference News ESC 2016

Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER

Michael O'Riordan

August 30, 2016

News Daily News

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Yael L. Maxwell

August 29, 2016

News Conference News ESC 2016

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Michael O'Riordan

August 27, 2016

News Daily News

The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say

Shelley Wood

July 19, 2016

News Daily News

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Michael O'Riordan

June 13, 2016

News Daily News

Does the Atherosclerotic Cardiovascular Disease Calculator Overestimate Patient Risk? The Debate Continues

Yael L. Maxwell

May 04, 2016

Advertisement

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

Interventional Cardiology Training Needs Defined for the First Time

No Stents in STEMI? With Careful Selection, Maybe

Transradial PCI Bests Femoral Access in Complex Cases: COLOR

FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

People Living in Amazon Rainforest Provide Clues to Coronary Protection

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study

When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis

Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Does the Atherosclerotic Cardiovascular Disease Calculator Overestimate Patient Risk? The Debate Continues

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content